Stanton A. Glantz, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Stanton A. Glantz, PhD

Professor, Department of Medicine; and Director, Center for Tobacco Control Research and Education, UCSF; Co-Leader, Tobacco Control Program, UCSF Helen Diller Family Comprehensive Cancer Center

glantz@medicine.ucsf.edu

Phone: (415) 476-3893 (voice)
Box 1390, UCSF
San Francisco, CA 94143-1390

UCSF Profiles

Cancer Center Membership

Program Member ยป Tobacco Control

Research Summary

I am a widely recognized researcher with a reputation for identifying and pursuing high-impact questions that make practical contributions to tobacco control policy development, evaluation, and implementation. I am skilled in both qualitative and quantitative research methods, having written several books on tobacco control policy and two successful statistics textbooks. As Director of the UCSF Center for Tobacco Control Research and Education (CTCRE), I have extensive practical experience in developing and managing transdisciplinary academic programs and bringing together faculty from many disciplines. I have supervised a total of 96 fellows and graduate students during my career and am the Program Director of the CTCRE Postdoctoral Training Program in collaboration with Dr. Pamela Ling. I have published in a broad range of tobacco control areas, including economic models of the effects of tobacco control policies on health outcomes and health care costs, social and environmental determinants of smoking and smoking cessation, young adult smoking, and health effects of secondhand smoke, particularly on heart disease. I wrote the first papers based on analyses of previously secret tobacco industry documents (published in JAMA in 1995). Since then, I have worked with the UCSF Library to build the Legacy Tobacco Documents Library, which now exceeds 83 million pages (and is growing). The library is a major international research resource that has supported preparation of over 900 publications, including 134 authored by me, and the CTCRE is an internationally known training resource for tobacco document research that serves postdoctoral fellows and many others working in tobacco control. I am also the Principal Investigator of the UCSF Tobacco Center of Regulatory Science (TCORS), which brings together a broad multidisciplinary group of faculty and provides training opportunities and funds for pilot studies for trainees with an interest in tobacco regulatory science.

Education

University of Cincinnati, OH, BS, 1969, Aerospace Engineering
Stanford University, CA, MS, 1970, Applied Mechanics
Stanford University, CA, PhD, 1973, Applied Mechanics and Engineering Economic Systems
Stanford University, CA, Postdoc, 1975, Cardiology
University of California San Francisco, CA, Postdoc, 1977, Cardiovascular Research


Professional Experience

  • 1965-68
    Student trainee, NASA Manned Spacecraft Center, Houston
  • 1969
    Aerospace Engineer, NASA Manned Spacecraft Center, Houston, TX
  • 1977-80
    Assistant Professor of Medicine in Residence, Univ. of California, San Francisco
  • 1981-82
    Associate Professor of Medicine in Residence, Univ. of California, San Francisco
  • 1983-87
    Associate Professor of Medicine, Univ. of California, San Francisco
  • 1987-present
    Professor of Medicine, Univ. of California, San Francisco
  • 2002-present
    Director, UCSF Center for Tobacco Control Research and Education

Honors & Awards

  • (1960)
    Eagle Scout, Bronze Palm
  • (1964)
    Outstanding future teacher
  • (1964)
    Bausch and Lomb Science Award
  • (1968)
    Tau Beta Pi (engineering)
  • (1969-72)
    NSF Graduate Fellowship
  • (1975-77)
    Bay Area Heart Research Committee Senior Research Fellowship
  • (1977-82)
    NIH Research Career Development Award
  • (1978)
    Best Paper Published in Computer
  • (1986)
    Janssen Lecture of Society for Cardiac Anesthesia
  • (1992)
    Fellow, American College of Cardiology
  • (1992-1997)
    Associate Editor, Journal of the American College of Cardiology
  • (1996)
    James Madison Freedom of Information Award, Society of Professional Journalists
  • (1996)
    Alton Ochsner Award of Special Recognition
  • (1997)
    UCSF Chancellor's Award for Public Service
  • (1998)
    American Society of Addiction Medicine Annual Award
  • (1998)
    Gleitsman Foundation Citizen Activist Award
  • (1999)

    American Heart Association Rashkind Lecture
  • (1999)
    "Taking the Heat" Award, University of California Tobacco Related Diseases Research Program
  • (2000)
    Ralph R. Sachs Lecture, UCLA
  • (2000)
    Common Cause Public Service Achievement Award
  • (2000)
    Robert Wood Johnson Innovators in Substance Abuse Control
  • (2002)
    FAMRI Cahan Distinguished Professor Award
  • (2003)
    American Public Health Association, Alcohol and Other Drugs section Lifetime Achievement Award
  • (2005)
    Elected to Institute of Medicine

Selected Publications

  1. Fallin A, Roditis M, Glantz S. The Carrot and the Stick? Strategies to Improve Compliance with College Campus Tobacco Policies. J Am Coll Health. 2016 Nov 21; 0.
    View on PubMed
  2. Dutra LM, Grana R, Glantz SA. Philip Morris research on precursors to the modern e-cigarette since 1990. Tob Control. 2016 Nov 15.
    View on PubMed
  3. Barry RA, Glantz S. A Public Health Framework for Legalized Retail Marijuana Based on the US Experience: Avoiding a New Tobacco Industry. PLoS Med. 2016 Sep; 13(9):e1002131.
    View on PubMed
  4. Kearns CE, Schmidt LA, Glantz SA. Sugar Industry and Coronary Heart Disease Research: A Historical Analysis of Internal Industry Documents. JAMA Intern Med. 2016 Sep 12.
    View on PubMed
  5. Cox E, Barry RA, Glantz S. E-cigarette Policymaking by Local and State Governments: 2009-2014. Milbank Q. 2016 Sep; 94(3):520-96.
    View on PubMed
  6. Lempert LK, Yerger V, Glantz SA. Letter by Lempert et al Regarding Article, "Menthol and Nonmenthol Cigarette Smoking: All-Cause Deaths, Cardiovascular Disease Deaths, and Other Causes of Death Among Blacks and Whites". Circulation. 2016 Aug 30; 134(9):e119-20.
    View on PubMed
  7. Hopkinson NS, Millett C, Glantz S, Arnott D, McNeill A. UK government should fund stop smoking media campaigns not give tax breaks to films with smoking imagery. Addiction. 2016 Nov; 111(11):2066-2067.
    View on PubMed
  8. Yeh JS, Bullen C, Glantz SA. CLINICAL DECISIONS. E-Cigarettes and Smoking Cessation. N Engl J Med. 2016 Jun 2; 374(22):2172-4.
    View on PubMed
  9. Lempert LK, Glantz S. Packaging colour research by tobacco companies: the pack as a product characteristic. Tob Control. 2016 Jun 2.
    View on PubMed
  10. Apollonio DE, Glantz SA. Minimum Ages of Legal Access for Tobacco in the United States From 1863 to 2015. Am J Public Health. 2016 Jul; 106(7):1200-7.
    View on PubMed
  11. Lightwood J, Glantz SA. Smoking Behavior and Healthcare Expenditure in the United States, 1992-2009: Panel Data Estimates. PLoS Med. 2016 May; 13(5):e1002020.
    View on PubMed
  12. Lempert LK, Glantz SA. Implications of Tobacco Industry Research on Packaging Colors for Designing Health Warning Labels. Nicotine Tob Res. 2016 May 4.
    View on PubMed
  13. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation - Authors' reply. Lancet Respir Med. 2016 Jun; 4(6):e26-7.
    View on PubMed
  14. Gendall P, Hoek J, Edwards R, Glantz S. Effect of Exposure to Smoking in Movies on Young Adult Smoking in New Zealand. PLoS One. 2016; 11(3):e0148692.
    View on PubMed
  15. Crosbie E, Sosa P, Glantz SA. Costa Rica's implementation of the Framework Convention on Tobacco Control: Overcoming decades of industry dominance. Salud Publica Mex. 2016 Feb; 58(1):62-70.
    View on PubMed
  16. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. 2016 Feb; 4(2):116-28.
    View on PubMed
  17. Liu J, Wang X, Narayan S, Glantz SA, Schick SF, Springer ML. Impairment of Endothelial Function by Little Cigar Secondhand Smoke. Tob Regul Sci. 2016 Jan 1; 2(1):56-63.
    View on PubMed
  18. Velicer C, Glantz SA. Hiding in the Shadows: Philip Morris and the Use of Third Parties to Oppose Ingredient Disclosure Regulations. PLoS One. 2015; 10(12):e0142032.
    View on PubMed
  19. Cheng KW, Liu F, Gonzalez M, Glantz S. The Effects of Workplace Clean Indoor Air Law Coverage on Workers' Smoking-Related Outcomes. Health Econ. 2015 Dec 7.
    View on PubMed
  20. Uang R, Hiilamo H, Glantz SA. Accelerated Adoption of Smoke-Free Laws After Ratification of the World Health Organization Framework Convention on Tobacco Control. Am J Public Health. 2016 Jan; 106(1):166-71.
    View on PubMed

Go to UCSF Profiles, powered by CTSI